These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1441293)

  • 1. [Structure-activity determination of physiological reactions of vasopressin and its analogs on the hemostasis system].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Vopr Med Khim; 1992; 38(1):42-4. PubMed ID: 1441293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-operative activation of coagulation--a stimulus to thrombosis mediated by vasopressin?
    Grant PJ; Tate GM; Davies JA; Williams NS; Prentice CR
    Thromb Haemost; 1986 Feb; 55(1):104-7. PubMed ID: 3085260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of cholinergic receptors in the reactions of the hemostasis system to vasopressin].
    Kalishevskaia TM; Golubeva MG; Solo'veva ME
    Fiziol Zh (1978); 1989; 35(5):9-14. PubMed ID: 2591588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
    Zhai P; Wakeham N; Loy JA; Zhang XC
    Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of modified forms of vasopressin on the rat hemostatic system].
    Grigor'eva ME; Kalishevskaia TM; Golubeva MG; Kaurov OA; Smirnova MP
    Izv Akad Nauk Ser Biol; 1997; (2):238-41. PubMed ID: 9190225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-sequential vasopressin peptides. Stereochemistry and biological activity.
    Zaoral M; Bláha I; Budesínský M; Machová A; Slaninová J
    J Pept Sci; 2000 Mar; 6(3):123-9. PubMed ID: 10759210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
    Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
    Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of fibrinolysis activators as a result of continuous stress.
    Lyutova LV; Andreenko GV; Karabasova MA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):356-60. PubMed ID: 2465230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
    Rijken DC; de Munk GA; Jie AF
    Thromb Haemost; 1993 Nov; 70(5):867-72. PubMed ID: 8128448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enzymic and non-enzymic fibrinolysis during intravenous administration of trypsin].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1984; 30(2):95-100. PubMed ID: 6540008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
    Mimeault M; Fournier A; Féthiere J; De Léan A
    Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system effects of the neurohypophyseal hormones and related peptides.
    de Wied D; Diamant M; Fodor M
    Front Neuroendocrinol; 1993 Oct; 14(4):251-302. PubMed ID: 8258377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAK: an essential motif for forming beta-turn structures and exhibiting the thrombolytic effect of P6A and its analogs.
    Zhao M; Jia X; Wang C; Li Q; Zhou K; Wang L; Liu H; Peng S
    Biochem Cell Biol; 2007 Dec; 85(6):730-40. PubMed ID: 18059531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.
    Cash JD; Gader AM; da Costa J
    Br J Haematol; 1974 Jun; 27(2):363-4. PubMed ID: 4367720
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
    Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
    Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.